期刊文献+

肝移植在乙型肝炎相关终末期肝病中的应用 被引量:1

下载PDF
导出
摘要 肝移植是目前治疗终末期肝病的唯一有效办法。乙型肝炎相关终末期肝病是我国肝移植最重要的适应证。我院于2005年11月21日和2006年2月16日分别对1例乙型肝炎后晚期肝硬化患者和1例肝细胞癌患者实行了同种异体背驮式肝移植,总结报道如下。
出处 《中国现代普通外科进展》 CAS 2008年第1期69-70,72,共3页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献8

  • 1Murray KF, Carithers RL Jr. American Association for the Study of Liver Diseases.AASLD practice guidelines:Evaluation of the patient for liver transplantation[J]. Hepatology, 2005, 41 (6): 1407-1432.
  • 2丁义涛.乙型肝炎相关性肝脏疾病的肝移植治疗[J].肝胆外科杂志,2005,13(2):91-93. 被引量:7
  • 3Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival[J]. Hepatology, 2001,33(6):1394-1403.
  • 4Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver Transpl, 2002,8:765-774.
  • 5Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection:implications for a strategy of salvage transplantation.[J]. Ann Surg, 2002, 235(3):373-382.
  • 6Bechstein WO, Guckelberger O, Kling N, et al. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma[J]. Transpl Int, 1998,11:s189-192.
  • 7Pokomy H, Gnant M, Rasoul-Roekenschaubs. Does additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma treated by liver transplantation [J]. Am J Transplant 2005,5 (4pt1):788-794.
  • 8Leung TW, Tang AM, Zee B,et al. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5 -fluorouracil chemotherapy[J]. Cancer, 2002,94 ( 2 ) :421-427.

二级参考文献6

  • 1Adam R, MeMaster P, O'grady JG, et al. Evolution of Liver Transplantation in Europe: Report of the European Liver Transplant Registry[J]. Liver Transpl,2003,9 : 1231-1243.
  • 2Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom[J]. Semin Liver Dis,2003,23:227-237.
  • 3Marsh JW, Dvorchik I. Liver organ allocation for hepatoeellularcarcinoma; Are we sure[J]? Liver Transpl, 2003,9 : 1394-1403.
  • 4Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellularcar cinoma in Child A Cirrhotic patients: Hepatic Resection versus transplantation[J]. Liver Transpl, 2003,9 : 513-520.
  • 5Hu RH, Ho MC, Wu YM, et al . Feasibility of salvage liver transplantation for patients with recurrent hepatoeellular carcinoma [J]. Clin Transplant, 2005,19 : 175-80.
  • 6Pokorny H, Gnant M, Rasoul-Rockenschaub S, et al. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation[J] ? Am J Transplant, 2005,5 : 788-794.

共引文献6

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部